Table 3.
Evaluation of the type of vascular access and the type of dialysis treatment.
| VARIABLE | HDg | IARAg | |||
|---|---|---|---|---|---|
| AVF | 21 (58.33) | 15 (41.67) | |||
| CVC | 6 (46.15) | 7 (53.85) | |||
| Test X2 (p-value) = 0.523 (0.449) | |||||
| HDF | 18 (52.94) | 16 (47.06) | |||
| HD | 6 (60.00) | 4 (40.00) | |||
| AFB | 3 (60.00) | 2 (40.00) | HF | . | . |
| Test X2 (p-value) = 0.210 (0.900) | |||||
AVF, Arteriovenous fistula; CVC, Central Venous Catheters; HDF, hemodiafiltration; HD, hemodialysis; AFB, acetate-free biofiltration; HF, hemofiltration.